Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07044323 · ClinicalTrials.gov registry record · NA
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment
A NA study of Amputation and Phantom Pain Following Amputation of Lower Limb, sponsored by Albert Einstein Healthcare Network.
- Recruiting
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 3
- Study locations
NCT07044323: Recruiting NA study of Amputation and Phantom Pain Following Amputation of Lower Limb, sponsored by Albert Einstein Healthcare Network.
NCT07044323 is a NA study of Amputation and Phantom Pain Following Amputation of Lower Limb that is actively recruiting participants, run by Albert Einstein Healthcare Network. The registered enrollment target is 44 participants, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (67% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07044323, a NA study of Amputation and Phantom Pain Following Amputation of Lower Limb, is actively recruiting participants, sponsored by Albert Einstein Healthcare Network.
- RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 3
- Study locations
Study Summary
After amputation of an arm or leg, up to 90% of subjects experience a "phantom limb", a phenomenon characterized by persistent feelings of the missing limb. Many subjects with a phantom limb experience intense pain in the missing extremity that is often poorly responsive to medications or other interventions. The study will explore the feasibility and efficacy of a home-based, active VR treatment for phantom limb pain (PLP).
Primary Outcome
the change in phantom limb pain score pre and post each VR intervention, at baseline, after the VR intervention and in the follow-up sessions as assessed using an 11-point numerical rating pain scale (0 - minimum score/no pain; 10 maximum score/pain as bad as you can imagine) assessing the current PLP level.
Conditions Studied
Interventions
- BEHAVIORAL Active Virtual Reality Treatment
Study Locations (3)
Pennsylvania
- Jefferson Moss Rehabilitation Research Institute - Philadelphia
- University of Pennsylvania - Philadelphia
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2025-06-16 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT07044323 shows while recruiting
NCT07044323 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (67% lower).
The record links to 2 conditions, with Amputation appearing as the primary indexed condition, and to 1 intervention - of which Active Virtual Reality Treatment is the first listed.
NCT07044323 reports a single indexed study location in Pennsylvania, Washington.
Frequently Asked Questions
What is clinical trial NCT07044323 about?
NCT07044323 is a clinical study titled "Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment". After amputation of an arm or leg, up to 90% of subjects experience a "phantom limb", a phenomenon characterized by persistent feelings of the missing limb. Many subjects with a phantom limb experience intense pain in the missing extremity that is often poorly responsive to medications or other inte...
What is the current status of trial NCT07044323?
This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2025-06-16. Estimated completion is 2026-05-31.
What conditions does trial NCT07044323 study?
This clinical trial studies the following conditions: Amputation, Phantom Pain Following Amputation of Lower Limb.
What interventions are being tested in trial NCT07044323?
The interventions under investigation include: Active Virtual Reality Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT07044323?
This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07044323 being conducted?
This trial has 3 study locations across Pennsylvania, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amputation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07044323's enrollment target sits among peer trials
44 22nd of 65 higher than 44 of 65 other Amputation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation
RECRUITING · NA
-
Hand Transplantation
RECRUITING · NA
-
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
RECRUITING · NA
-
Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?
RECRUITING · NA
-
Intuitive Control of a Hybrid Prosthetic Leg During Ambulation
RECRUITING · NA
-
Hybrid Pump Technology
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI